176 related articles for article (PubMed ID: 38665263)
41. Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death.
Perros P; Nirantharakumar K; Hegedüs L
Eur J Endocrinol; 2021 Feb; 184(2):C1-C3. PubMed ID: 33306038
[TBL] [Abstract][Full Text] [Related]
42. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
Kabadi UM; Cech R
J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
[TBL] [Abstract][Full Text] [Related]
43. Severe hypothyroidism in patients dependent on prolonged thyroxine infusion through a jejunostomy.
Smyrniotis V; Vaos N; Arkadopoulos N; Kostopanagiotou G; Theodoraki K; Lambrou A
Clin Nutr; 2000 Feb; 19(1):65-7. PubMed ID: 10700537
[TBL] [Abstract][Full Text] [Related]
44. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients.
Liel Y; Harman-Boehm I; Shany S
J Clin Endocrinol Metab; 1996 Feb; 81(2):857-9. PubMed ID: 8636317
[TBL] [Abstract][Full Text] [Related]
45. Overt and subclinical hypothyroidism: who to treat and how.
Khandelwal D; Tandon N
Drugs; 2012 Jan; 72(1):17-33. PubMed ID: 22191793
[TBL] [Abstract][Full Text] [Related]
46. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment.
Hoermann R; Midgley JE; Giacobino A; Eckl WA; Wahl HG; Dietrich JW; Larisch R
Clin Endocrinol (Oxf); 2014 Dec; 81(6):907-15. PubMed ID: 24953754
[TBL] [Abstract][Full Text] [Related]
47. Unusual malabsorption of levothyroxine.
Jauk B; Mikosch P; Gallowitsch HJ; Kresnik E; Molnar M; Gomez I; Lind P
Thyroid; 2000 Jan; 10(1):93-5. PubMed ID: 10691319
[TBL] [Abstract][Full Text] [Related]
48. Editorial: Levothyroxine Therapy in Patients With Hypothyroidism.
Antonelli A; Wartofsky L; Miccoli P
Front Endocrinol (Lausanne); 2021; 12():734895. PubMed ID: 34354674
[No Abstract] [Full Text] [Related]
49. Effects of long-term treatment with thyroxine on pituitary TSH secretion and heart action in patients with hypothyroidism.
Yamauchi K; Takasu N; Ichikawa K; Yamada T; Aizawa T
Acta Endocrinol (Copenh); 1984 Oct; 107(2):218-24. PubMed ID: 6495989
[TBL] [Abstract][Full Text] [Related]
50. Liquid levothyroxine improves thyroid control in patients with different hypothyroidism aetiology and variable adherence - case series and review.
Ruchała M; Bossowski A; Brzozka MM; Gietka-Czernel M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Syrenicz A; Zgliczyński W
Endokrynol Pol; 2022; 73(5):893-902. PubMed ID: 36621916
[TBL] [Abstract][Full Text] [Related]
51. Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects.
Samuels MH; Kolobova I; Niederhausen M; Janowsky JS; Schuff KG
J Clin Endocrinol Metab; 2018 May; 103(5):1997-2008. PubMed ID: 29509918
[TBL] [Abstract][Full Text] [Related]
52. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.
Celi FS; Zemskova M; Linderman JD; Babar NI; Skarulis MC; Csako G; Wesley R; Costello R; Penzak SR; Pucino F
Clin Endocrinol (Oxf); 2010 May; 72(5):709-15. PubMed ID: 20447070
[TBL] [Abstract][Full Text] [Related]
53. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis.
Tagami T; Tamanaha T; Shimazu S; Honda K; Nanba K; Nomura H; Yoriko SU; Usui T; Shimatsu A; Naruse M
Endocr J; 2010; 57(3):253-8. PubMed ID: 20032565
[TBL] [Abstract][Full Text] [Related]
54. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies.
Checchi S; Montanaro A; Pasqui L; Ciuoli C; De Palo V; Chiappetta MC; Pacini F
J Clin Endocrinol Metab; 2008 Feb; 93(2):465-9. PubMed ID: 18042648
[TBL] [Abstract][Full Text] [Related]
55. [Effect of treatment with levothyroxine in the lipid profile of the patients with subclinical hypothyroidism].
Prats Julià M
Endocrinol Nutr; 2009 Jan; 56(1):13-7. PubMed ID: 19627704
[TBL] [Abstract][Full Text] [Related]
56. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
[TBL] [Abstract][Full Text] [Related]
57. Atypical celiac disease as cause of increased need for thyroxine: a systematic study.
Virili C; Bassotti G; Santaguida MG; Iuorio R; Del Duca SC; Mercuri V; Picarelli A; Gargiulo P; Gargano L; Centanni M
J Clin Endocrinol Metab; 2012 Mar; 97(3):E419-22. PubMed ID: 22238404
[TBL] [Abstract][Full Text] [Related]
58. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
[TBL] [Abstract][Full Text] [Related]
59. Serum TSH concentration as an aid to monitoring compliance with thyroid hormone therapy in hypothyroidism.
England ML; Hershman JM
Am J Med Sci; 1986 Nov; 292(5):264-6. PubMed ID: 3777010
[TBL] [Abstract][Full Text] [Related]
60. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound.
Rosário PW; Bessa B; Valadão MM; Purisch S
Thyroid; 2009 Jan; 19(1):9-12. PubMed ID: 19021461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
